See more : Dune Acquisition Corporation (DUNEW) Income Statement Analysis – Financial Results
Complete financial analysis of Balchem Corporation (BCPC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Balchem Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- China Resources Pharmaceutical Group Limited (3320.HK) Income Statement Analysis – Financial Results
- Tikehau Capital (TKKHF) Income Statement Analysis – Financial Results
- NSE S.A. (ALNSE.PA) Income Statement Analysis – Financial Results
- Ibere Pharmaceuticals (IBER) Income Statement Analysis – Financial Results
- Veeva Systems Inc. (0LO3.L) Income Statement Analysis – Financial Results
Balchem Corporation (BCPC)
About Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 922.44M | 942.36M | 799.02M | 703.64M | 643.71M | 643.68M | 594.79M | 553.20M | 552.49M | 541.38M | 337.17M | 310.39M | 291.87M | 255.07M | 219.44M | 232.05M | 176.20M | 100.91M | 839.10M | 67.41M | 61.88M | 60.20M | 46.14M | 33.20M | 29.70M | 28.70M | 28.60M | 26.40M | 25.00M | 18.90M | 14.70M | 12.70M | 12.70M | 10.80M | 9.60M | 8.40M | 6.80M | 5.80M | 5.20M |
| Cost of Revenue | 620.38M | 661.91M | 555.85M | 479.75M | 432.34M | 439.43M | 405.78M | 372.34M | 384.40M | 397.21M | 239.75M | 220.85M | 205.87M | 177.03M | 152.48M | 179.47M | 129.27M | 66.90M | 54.42M | 43.60M | 40.72M | 36.89M | 28.22M | 17.14M | 15.60M | 15.60M | 15.30M | 13.70M | 12.70M | 10.20M | 7.90M | 6.60M | 6.60M | 5.60M | 5.50M | 4.40M | 3.40M | 2.90M | 2.70M |
| Gross Profit | 302.06M | 280.45M | 243.17M | 223.90M | 211.37M | 204.25M | 189.01M | 180.86M | 168.10M | 144.17M | 97.42M | 89.54M | 86.00M | 78.04M | 66.96M | 52.58M | 46.93M | 34.01M | 784.68M | 23.81M | 21.15M | 23.31M | 17.93M | 16.06M | 14.10M | 13.10M | 13.30M | 12.70M | 12.30M | 8.70M | 6.80M | 6.10M | 6.10M | 5.20M | 4.10M | 4.00M | 3.40M | 2.90M | 2.50M |
| Gross Profit Ratio | 32.75% | 29.76% | 30.43% | 31.82% | 32.84% | 31.73% | 31.78% | 32.69% | 30.43% | 26.63% | 28.89% | 28.85% | 29.47% | 30.59% | 30.51% | 22.66% | 26.63% | 33.70% | 93.52% | 35.32% | 34.19% | 38.72% | 38.85% | 48.36% | 47.47% | 45.64% | 46.50% | 48.11% | 49.20% | 46.03% | 46.26% | 48.03% | 48.03% | 48.15% | 42.71% | 47.62% | 50.00% | 50.00% | 48.08% |
| Research & Development | 15.05M | 12.19M | 13.52M | 10.33M | 11.38M | 11.59M | 9.31M | 7.33M | 5.99M | 4.81M | 3.62M | 3.42M | 2.89M | 3.19M | 3.30M | 2.88M | 2.51M | 2.02M | 2.05M | 1.75M | 2.08M | 1.91M | 1.63M | 1.07M | 1.30M | 1.00M | 1.10M | 800.00K | 800.00K | 600.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 55.73M | 55.67M | 41.74M | 43.79M | 36.51M | 27.69M | 27.73M | 27.53M | 21.90M | 21.46M | 12.28M | 10.41M | 10.60M | 9.47M | 8.65M | 20.35M | 18.51M | 12.83M | 9.72M | 9.26M | 10.05M | 9.22M | 8.14M | 7.03M | 5.80M | 5.60M | 6.80M | 7.40M | 8.00M | 5.90M | 5.20M | 4.90M | 4.30M | 3.60M | 3.10M | 2.90M | 2.50M | 2.10M | 1.90M |
| Selling & Marketing | 74.40M | 67.41M | 60.41M | 58.63M | 60.93M | 57.22M | 54.72M | 55.17M | 46.26M | 35.76M | 15.92M | 15.93M | 16.28M | 15.61M | 14.35M | 0.00 | 11.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 130.13M | 123.07M | 102.15M | 102.42M | 97.44M | 84.91M | 82.45M | 82.70M | 68.15M | 57.22M | 28.20M | 26.34M | 26.89M | 25.08M | 23.00M | 20.35M | 18.51M | 12.83M | 9.72M | 9.26M | 10.05M | 9.22M | 8.14M | 7.03M | 5.80M | 5.60M | 6.80M | 7.40M | 8.00M | 5.90M | 5.20M | 4.90M | 4.30M | 3.60M | 3.10M | 2.90M | 2.50M | 2.10M | 1.90M |
| Other Expenses | 0.00 | -11.44M | -2.27M | -4.73M | -6.08M | -8.72M | -8.77M | -7.90M | -309.00K | -5.09M | -37.00K | 67.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00M | 1.70M | 1.10M | 1.40M | 800.00K | 700.00K | 500.00K | 500.00K | 500.00K | 500.00K | 400.00K | 400.00K | 300.00K | 300.00K | 300.00K |
| Operating Expenses | 142.86M | 135.27M | 115.67M | 112.75M | 108.81M | 96.50M | 91.75M | 90.02M | 74.14M | 62.03M | 31.82M | 29.76M | 29.78M | 28.27M | 26.30M | 23.23M | 21.02M | 14.84M | 11.78M | 11.01M | 12.14M | 11.13M | 9.77M | 8.10M | 9.10M | 8.30M | 9.00M | 9.60M | 9.60M | 7.20M | 5.70M | 5.40M | 4.80M | 4.10M | 3.50M | 3.30M | 2.80M | 2.40M | 2.20M |
| Cost & Expenses | 763.25M | 797.17M | 671.52M | 592.50M | 541.15M | 535.93M | 497.54M | 462.37M | 458.54M | 459.24M | 271.57M | 250.62M | 235.64M | 205.30M | 178.78M | 202.70M | 150.30M | 81.74M | 66.19M | 54.61M | 52.86M | 48.01M | 37.99M | 25.25M | 24.70M | 23.90M | 24.30M | 23.30M | 22.30M | 17.40M | 13.60M | 12.00M | 11.40M | 9.70M | 9.00M | 7.70M | 6.20M | 5.30M | 4.90M |
| Interest Income | 0.00 | 2.25M | 2.26M | 2.28M | 1.36M | 0.00 | 12.00K | 9.00K | 9.00K | 64.00K | 277.00K | 10.00K | 184.00K | 289.00K | 107.00K | 107.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 22.61M | 10.27M | 2.46M | 4.44M | 5.96M | 7.61M | 7.54M | 7.27M | 6.59M | 5.15M | 24.00K | 10.00K | 84.00K | 90.00K | 209.00K | 963.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 54.94M | 51.30M | 45.76M | 49.00M | 45.58M | 43.99M | 43.91M | 45.68M | 39.96M | 30.52M | 10.47M | 9.64M | 9.29M | 8.56M | 8.13M | 7.79M | 6.38M | 3.45M | 2.81M | 3.27M | 3.53M | 2.92M | 2.62M | 2.02M | 2.00M | 1.70M | 1.10M | 1.40M | 800.00K | 700.00K | 500.00K | 500.00K | 500.00K | 500.00K | 400.00K | 400.00K | 300.00K | 300.00K | 300.00K |
| EBITDA | 214.81M | 197.57M | 175.70M | 162.13M | 148.42M | 150.26M | 139.94M | 135.88M | 133.02M | 117.40M | 76.32M | 69.50M | 66.11M | 58.78M | 48.94M | 37.18M | 32.28M | 22.61M | 19.71M | 16.07M | 12.54M | 15.10M | 10.78M | 7.95M | 7.00M | 6.50M | 5.40M | 4.50M | 3.50M | 2.20M | 1.60M | 1.20M | 1.80M | 1.60M | 1.00M | 1.10M | 900.00K | 800.00K | 600.00K |
| EBITDA Ratio | 23.29% | 20.91% | 22.07% | 23.08% | 23.06% | 23.68% | 23.81% | 24.77% | 24.18% | 20.81% | 22.63% | 22.36% | 22.51% | 22.98% | 18.55% | 16.03% | 18.14% | 22.40% | 92.44% | 23.82% | 20.27% | 25.08% | 22.29% | 30.03% | 23.57% | 22.65% | 18.88% | 17.42% | 14.00% | 11.64% | 11.56% | 11.81% | 14.17% | 14.81% | 10.42% | 13.10% | 13.24% | 13.79% | 9.62% |
| Operating Income | 159.19M | 145.19M | 127.50M | 111.15M | 102.55M | 107.75M | 97.26M | 90.84M | 93.96M | 82.14M | 65.60M | 59.78M | 56.23M | 49.77M | 40.66M | 29.35M | 25.91M | 19.16M | 16.90M | 12.80M | 9.02M | 12.19M | 8.16M | 5.94M | 5.00M | 4.80M | 4.30M | 3.10M | 2.70M | 1.50M | 1.10M | 700.00K | 1.30M | 1.10M | 600.00K | 700.00K | 600.00K | 500.00K | 300.00K |
| Operating Income Ratio | 17.26% | 15.41% | 15.96% | 15.80% | 15.93% | 16.74% | 16.35% | 16.42% | 17.01% | 15.17% | 19.46% | 19.26% | 19.26% | 19.51% | 18.53% | 12.65% | 14.70% | 18.99% | 2.01% | 18.98% | 14.57% | 20.24% | 17.67% | 17.89% | 16.84% | 16.72% | 15.03% | 11.74% | 10.80% | 7.94% | 7.48% | 5.51% | 10.24% | 10.19% | 6.25% | 8.33% | 8.82% | 8.62% | 5.77% |
| Total Other Income/Expenses | -21.93M | -11.44M | -2.27M | -4.73M | -6.08M | -8.07M | -8.42M | -7.90M | -6.89M | -5.09M | 216.00K | 67.00K | 513.00K | 361.00K | -57.00K | -917.00K | -1.08M | -61.00K | 288.00K | -82.00K | -252.00K | -340.00K | 214.00K | 58.00K | -100.00K | -100.00K | 0.00 | -200.00K | -300.00K | -300.00K | -300.00K | -400.00K | -100.00K | -200.00K | -100.00K | -100.00K | 100.00K | 0.00 | 100.00K |
| Income Before Tax | 137.26M | 133.75M | 125.23M | 106.42M | 96.48M | 99.03M | 88.49M | 82.93M | 87.06M | 77.05M | 65.82M | 59.84M | 56.74M | 50.13M | 40.60M | 28.43M | 24.83M | 19.10M | 17.19M | 12.72M | 8.76M | 11.85M | 8.37M | 6.00M | 4.90M | 4.70M | 4.30M | 2.90M | 2.40M | 1.20M | 800.00K | 300.00K | 1.20M | 900.00K | 500.00K | 600.00K | 700.00K | 500.00K | 400.00K |
| Income Before Tax Ratio | 14.88% | 14.19% | 15.67% | 15.12% | 14.99% | 15.38% | 14.88% | 14.99% | 15.76% | 14.23% | 19.52% | 19.28% | 19.44% | 19.65% | 18.50% | 12.25% | 14.09% | 18.93% | 2.05% | 18.86% | 14.16% | 19.68% | 18.14% | 18.06% | 16.50% | 16.38% | 15.03% | 10.98% | 9.60% | 6.35% | 5.44% | 2.36% | 9.45% | 8.33% | 5.21% | 7.14% | 10.29% | 8.62% | 7.69% |
| Income Tax Expense | 28.72M | 28.38M | 29.13M | 21.79M | 16.81M | 20.46M | -1.58M | 26.96M | 27.34M | 24.23M | 20.94M | 19.84M | 17.97M | 16.85M | 13.82M | 9.38M | 8.71M | 6.82M | 6.24M | 4.69M | 3.13M | 4.43M | 3.26M | 2.27M | 1.80M | 1.70M | 1.50M | 1.00M | 800.00K | 400.00K | 200.00K | 100.00K | 400.00K | 300.00K | 200.00K | 200.00K | 300.00K | 200.00K | -100.00K |
| Net Income | 108.54M | 105.37M | 96.10M | 84.62M | 79.67M | 78.57M | 90.07M | 55.97M | 59.72M | 52.83M | 44.87M | 40.01M | 38.77M | 33.28M | 26.79M | 19.05M | 16.12M | 12.28M | 10.95M | 8.03M | 5.64M | 7.42M | 5.11M | 3.73M | 3.10M | 3.00M | 2.80M | 1.90M | 1.60M | 800.00K | 600.00K | 200.00K | 800.00K | 600.00K | 300.00K | 400.00K | 400.00K | 300.00K | 400.00K |
| Net Income Ratio | 11.77% | 11.18% | 12.03% | 12.03% | 12.38% | 12.21% | 15.14% | 10.12% | 10.81% | 9.76% | 13.31% | 12.89% | 13.28% | 13.05% | 12.21% | 8.21% | 9.15% | 12.17% | 1.31% | 11.91% | 9.11% | 12.32% | 11.07% | 11.23% | 10.44% | 10.45% | 9.79% | 7.20% | 6.40% | 4.23% | 4.08% | 1.57% | 6.30% | 5.56% | 3.13% | 4.76% | 5.88% | 5.17% | 7.69% |
| EPS | 3.38 | 3.29 | 2.98 | 2.63 | 2.48 | 2.44 | 2.81 | 1.76 | 1.92 | 1.71 | 1.51 | 1.36 | 1.36 | 1.19 | 0.98 | 0.71 | 0.61 | 0.47 | 0.42 | 0.32 | 0.23 | 0.31 | 0.22 | 0.16 | 0.13 | 0.12 | 0.11 | 0.08 | 0.07 | 0.04 | 0.03 | 0.01 | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
| EPS Diluted | 3.35 | 3.25 | 2.94 | 2.60 | 2.45 | 2.42 | 2.79 | 1.75 | 1.89 | 1.69 | 1.45 | 1.32 | 1.28 | 1.12 | 0.93 | 0.67 | 0.58 | 0.45 | 0.41 | 0.31 | 0.22 | 0.30 | 0.21 | 0.15 | 0.12 | 0.12 | 0.11 | 0.08 | 0.07 | 0.04 | 0.03 | 0.01 | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 32.11M | 32.02M | 32.22M | 32.18M | 32.14M | 32.26M | 32.02M | 31.76M | 31.16M | 30.85M | 29.62M | 29.45M | 28.57M | 27.96M | 28.87M | 26.95M | 26.57M | 26.31M | 26.08M | 25.43M | 24.40M | 24.07M | 23.52M | 23.60M | 24.52M | 24.90M | 24.40M | 23.65M | 24.30M | 22.47M | 23.33M | 25.28M | 23.79M | 21.66M | 21.66M | 22.47M | 25.27M | 25.28M | 22.47M |
| Weighted Avg Shares Out (Dil) | 32.45M | 32.39M | 32.67M | 32.50M | 32.51M | 32.45M | 32.23M | 31.92M | 31.64M | 31.17M | 30.85M | 30.35M | 30.24M | 29.62M | 28.87M | 28.52M | 27.79M | 27.49M | 26.94M | 26.17M | 25.37M | 25.03M | 24.64M | 24.20M | 24.91M | 25.31M | 24.40M | 23.65M | 24.30M | 22.47M | 23.33M | 25.28M | 23.79M | 21.66M | 21.66M | 22.47M | 25.27M | 25.28M | 22.47M |
Balchem Q3: A Solid Performer Is Seeing A Soft 2023
Balchem Corporation shares have come under pressure after a tough 2023 so far. The company has a strong track record and has grown its sales to nearly a billion dollars. Recent Balchem Corporation Q3 financial results show a decline in...
Balchem Corporation (BCPC) Q3 2023 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q3 2023 Earnings Conference Call October 27, 2023 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Anthony Polak - Aegis...
Blachem (BCPC) Q3 Earnings and Revenues Lag Estimates
Blachem (BCPC) came out with quarterly earnings of $0.90 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.78 per share a year ago.
Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04
MONTVALE, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today third quarter net sales of $229.9 million for 2023, compared to net sales of $244.3 million in the prior year quarter.
Blachem (BCPC) Earnings Expected to Grow: Should You Buy?
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 27, 2023
MONTVALE, N.J., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 27th at 11:00 AM Eastern Time (ET) to review third quarter results.
MATV or BCPC: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Mativ Holdings (MATV) and Blachem (BCPC). But which of these two stocks offers value investors a better bang for their buck right now?
Balchem Corporation (BCPC) Q2 2023 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q2 2023 Earnings Conference Call July 28, 2023 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C....
Blachem (BCPC) Surpasses Q2 Earnings Estimates
Blachem (BCPC) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.92 per share a year ago.
Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06
MONTVALE, N.J., July 28, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today second quarter net sales of $231.3 million for 2023, compared to net sales of $236.7 million in the prior year quarter. Second quarter net earnings were...
Source: https://incomestatements.info
Category: Stock Reports